Literature DB >> 12750998

The abnormalities of chromosome 8 in two hepatocellular carcinoma cell clones with the same genetic background and different metastatic potential.

Jiong Yang1, Lun-Xiu Qin, Sheng-Long Ye, Yin-Kun Liu, Yan Li, Dong-Mei Gao, Jie Chen, Zhao-You Tang.   

Abstract

PURPOSE: Two hepatocellular carcinoma (HCC) cell clones named MHCC97-H and MHCC97-L with different metastatic potential have recently been established from the same parent cell line MHCC97 in our institute. The cytogenetic alterations of these two clones were investigated in this study to explore the possible clues to the mechanism involved in HCC metastasis.
METHODS: Their chromosomal aberrations were analyzed with comparative genomic hybridization (CGH), chromosome-specific painting, and two-color fluorescence in situ hybridization (FISH).
RESULTS: The aberrations were found in a total of 17 chromosomes, and six kinds of the aberrations including gains of 1q, 7q, 8q, 20, and the losses of 8p23, 21q were found both in the two cell clones and their parent cell line MHCC97. Using modified CGH, with the DNA of MHCC97-L as control to test the MHCC97-H clone, the loss of 8p23 and the gain of 1q31-32, 8q21.3-22, 13q22, 17q22 were highlighted, and the most significant finding was on chromosome 8. Dual color FISH combining a pericentromeric probe and a BAC probe mapping at 8q23.1 was then performed to verify this result, and the signal ratios of the BAC to centromere were 1.43 in MHCC97-H and 1.45 in MHCC97-L, confirming the over-representations at 8q in both cells. Another interesting finding in the dual-color metaphase FISH was the intrachromosomal translocation of 8q to 8p (looked like an isochromosome 8) and non-reciprocal translocation of part of 8q to 4q, which was further clarified and proved by the FISH with whole chromosome 8 painting probe.
CONCLUSIONS: The high copies amplification on 8q, the formation of isochromosome 8, non-reciprocal translocation of partial 8q to 4q, and loss of 8p occurred at the same time and are the characteristic chromosomal aberrations of the two cell clones. The chromosome 8p, especially 8p23, might harbor some novel genes related to the HCC metastasis.

Entities:  

Mesh:

Year:  2003        PMID: 12750998     DOI: 10.1007/s00432-003-0436-8

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  30 in total

1.  Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization.

Authors:  T Nishizaki; S DeVries; K Chew; W H Goodson; B M Ljung; A Thor; F M Waldman
Journal:  Genes Chromosomes Cancer       Date:  1997-08       Impact factor: 5.006

2.  Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.

Authors:  Y Li; Z Y Tang; S L Ye; Y K Liu; J Chen; Q Xue; J Chen; D M Gao; W H Bao
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

3.  Recurrence after resection of alpha-fetoprotein-positive hepatocellular carcinoma.

Authors:  X D Zhou; Z Y Tang; Y Q Yu; B H Yang; J Z Lu; Z Y Lin; Z C Ma; B H Zhang
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Chromosomal gains and losses are uncommon in hairy cell leukemia: a study based on comparative genomic hybridization and interphase fluorescence in situ hybridization.

Authors:  J Dierlamm; M Stefanova; I Wlodarska; L Michaux; K Hinz; E M Penas; B Maes; A Hagemeijer; C De Wolf-Peeters; D K Hossfeld
Journal:  Cancer Genet Cytogenet       Date:  2001-07-15

5.  The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma.

Authors:  L X Qin; Z Y Tang; J S Sham; Z C Ma; S L Ye; X D Zhou; Z Q Wu; J M Trent; X Y Guan
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

6.  Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma.

Authors:  C Liao; M Zhao; H Song; K Uchida; K K Yokoyama; T Li
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

7.  Assessment of chromosomal losses and gains in hepatocellular carcinoma.

Authors:  Joon Chang; Nam-Gyun Kim; Zhe Piao; Chanil Park; Kang-Sik Park; Young-Ki Paik; Woo-Jung Lee; Byong Ro Kim; Hoguen Kim
Journal:  Cancer Lett       Date:  2002-08-28       Impact factor: 8.679

8.  Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization.

Authors:  L Wilkens; M Bredt; P Flemming; S Kubicka; J Klempnauer; H Kreipe
Journal:  Am J Clin Pathol       Date:  2000-12       Impact factor: 2.493

9.  Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization.

Authors:  Ann D Thor; Clarence Eng; Sandy Devries; Michael Paterakos; William G Watkin; Susan Edgerton; Dan H Moore; Joan Etzell; Frederic M Waldman
Journal:  Hum Pathol       Date:  2002-06       Impact factor: 3.466

Review 10.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors.

Authors:  O P Kallioniemi; A Kallioniemi; J Piper; J Isola; F M Waldman; J W Gray; D Pinkel
Journal:  Genes Chromosomes Cancer       Date:  1994-08       Impact factor: 5.006

View more
  2 in total

Review 1.  A decade's studies on metastasis of hepatocellular carcinoma.

Authors:  Zhao-You Tang; Sheng-Long Ye; Yin-Kun Liu; Lun-Xiu Qin; Hui-Chuan Sun; Qin-Hai Ye; Lu Wang; Jian Zhou; Shuang-Jian Qiu; Yan Li; Xue-Ning Ji; Hu Liu; Jing-Ling Xia; Zhi-Quan Wu; Jia Fan; Zeng-Chen Ma; Xin-Da Zhou; Zhi-Ying Lin; Kang-Da Liu
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-18       Impact factor: 4.553

2.  Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98.

Authors:  Chao-Yang Lou; Ying-Ming Feng; Ai-Rong Qian; Yu Li; Hao Tang; Peng Shang; Zhi-Nan Chen
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.